Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPL and Diquafosol in Dry Eye
NCT05694026Completed
- Sponsor
- He Eye Hospital
- Start
- Mar 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of diquafosol in dry eye disease (DED), sponsored by He Eye Hospital. Primary endpoint: Non-invasive tear break-up time at 28 days. Started Mar 2023; status: completed.
02
Drugs
diquafosol
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05694026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05694026.